These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35025986)

  • 21. Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study.
    Hohnloser SH; Basic E; Nabauer M
    Thromb Haemost; 2019 Jun; 119(6):882-893. PubMed ID: 30900220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF).
    Kim H; Lee YS; Kim TH; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Shim J; Uhm JS; Park HW; Choi EK; Kim JB; Kim C; Kim J; Joung B
    Korean J Intern Med; 2020 Jan; 35(1):99-108. PubMed ID: 31014064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
    Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
    Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New oral anticoagulants for the prevention of thromboembolic complications in atrial fibrillation: a single centre experience.
    Gorczyca-Michta I; Wożakowska-Kapłon B
    Kardiol Pol; 2015; 73(2):85-93. PubMed ID: 25179482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Li YG; Miyazawa K; Wolff A; Zubaid M; Alsheikh-Ali AA; Sulaiman K; Lip GYH
    Int J Cardiol; 2019 Jan; 274():158-162. PubMed ID: 30291008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-specific trends of atrial fibrillation-related ischaemic stroke and transient ischaemic attack, anticoagulant use and risk factor profile in Chinese population: a 15-year study.
    Soo Y; Chan N; Leung KT; Chen XY; Mok V; Wong L; Leung T
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):744-748. PubMed ID: 28550068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey.
    Potpara TS; Trendafilova E; Dan GA; Goda A; Kusljugic Z; Manola S; Music L; Gjini V; Pojskic B; Popescu MI; Georgescu CA; Dimitrova ES; Kamenova D; Ekmeciu U; Mrsic D; Nenezic A; Brusich S; Milanov S; Zeljkovic I; Lip GYH;
    Adv Ther; 2017 Aug; 34(8):2043-2057. PubMed ID: 28795332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.
    Krittayaphong R; Phrommintikul A; Winijkul A; Methavigul K; Komoltri C; Kaewkumdee P; Yindeengam A;
    BMJ Open; 2021 May; 11(5):e043862. PubMed ID: 33958338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.
    Joosten LPT; van Doorn S; Hoes AW; Nierman MC; Wiersma NM; Koek HL; Hemels MEW; Huisman MV; Roes KC; van den Bor RM; Buding WF; Rutten FH; Geersing GJ
    BMJ Open; 2019 Dec; 9(12):e032488. PubMed ID: 31888928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
    Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Chao TF; Joung B; Takahashi Y; Lim TW; Choi EK; Chan YH; Guo Y; Sriratanasathavorn C; Oh S; Okumura K; Lip GYH
    Thromb Haemost; 2022 Jan; 122(1):20-47. PubMed ID: 34773920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry.
    Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Diemberger I; Tavazzi L; Maggioni AP; Lip GYH; ;
    Europace; 2018 May; 20(5):747-757. PubMed ID: 29016832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study.
    Yang WY; Du X; Jiang C; He L; Fawzy AM; Wang L; Liu C; Xia SJ; Chang SS; Guo XY; Li SN; Tang RB; Liu N; Bai R; Sang CH; Jiang CX; Yu RH; Long DY; Dong JZ; Lip GYH; Ma CS
    Europace; 2020 Jan; 22(1):90-99. PubMed ID: 31909431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients.
    Schäfer A; Flierl U; Berliner D; Bauersachs J
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):555-568. PubMed ID: 32350792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).
    Kirchhof P; Ammentorp B; Darius H; De Caterina R; Le Heuzey JY; Schilling RJ; Schmitt J; Zamorano JL
    Europace; 2014 Jan; 16(1):6-14. PubMed ID: 24084680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation.
    Ooi AJQ; Wong C; Tan TWE; Ng TP; Teo YN; Teo YH; Syn NL; Djohan AH; Lim Y; Yeo LLL; Tan BYQ; Chan MY; Poh KK; Kong WKF; Chai P; Yeo TC; Yip JW; Kuntjoro I; Sia CH
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1589-1600. PubMed ID: 35941300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.